Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Physiology & Behavior|January 27, 2010
Mini-review: polybrominated diphenyl ether (PBDE) flame retardants as potential autism risk factorsAnne MesserBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 21, 2006
The therapeutic potential of intrabodies in neurologic disorders: focus on Huntington and Parkinson diseasesAnne Messer, Julie McLearPlos One|January 5, 2012
Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragmentsDavid C Butler, Anne MesserBrain Research. Developmental Brain Research|September 8, 2004
Early postnatal Purkinje cells from staggerer mice undergo aberrant development in vitro with characteristic morphologic and gene expression abnormalitiesL Thomas Shirley, Anne MesserNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 8, 2013
Intrabodies as neuroprotective therapeuticsAnne Messer, Shubhada N JoshiBrain Research. Molecular Brain Research|February 19, 2004
A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's diseaseRobert C Murphy, Anne MesserNeurobiology of Disease|November 1, 2019
Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disordersAnne Messer, David C ButlerMolecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Intrabody applications in neurological disorders: progress and future prospectsTodd W Miller, Anne MesserNeurobiology of Disease|August 26, 2010
Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's diseaseTyisha Hathorn, Abigail Snyder-Keller, Anne MesserBrain Research|March 27, 2004
Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic miceValerie J Bolivar, Kevin Manley, Anne MesserPageof 5